These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38513135)

  • 1. Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression.
    Fléchon L; Arib I; Dutta AK; Hasan Bou Issa L; Sklavenitis-Pistofidis R; Tilmont R; Stewart C; Dubois R; Poulain S; Copin MC; Javed S; Nudel M; Cavalieri D; Escure G; Gower N; Chauvet P; Gazeau N; Saade C; Thiam MB; Ouelkite-Oumouchal A; Gaggero S; Cailliau É; Faiz S; Carpentier O; Duployez N; Idziorek T; Mortier L; Figeac M; Preudhomme C; Quesnel B; Mitra S; Morschhauser F; Getz G; Ghobrial IM; Manier S
    Blood Adv; 2024 Jun; 8(12):3109-3119. PubMed ID: 38513135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High-throughput sequencing of the T cell receptor β gene identifies aggressive early-stage mycosis fungoides.
    de Masson A; O'Malley JT; Elco CP; Garcia SS; Divito SJ; Lowry EL; Tawa M; Fisher DC; Devlin PM; Teague JE; Leboeuf NR; Kirsch IR; Robins H; Clark RA; Kupper TS
    Sci Transl Med; 2018 May; 10(440):. PubMed ID: 29743350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular staging of lymph nodes from 60 patients with mycosis fungoides and Sézary syndrome: correlation with histopathology and outcome suggests prognostic relevance in mycosis fungoides.
    Fraser-Andrews EA; Mitchell T; Ferreira S; Seed PT; Russell-Jones R; Calonje E; Whittaker SJ
    Br J Dermatol; 2006 Oct; 155(4):756-62. PubMed ID: 16965425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
    Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
    Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic miRNA classifier in early-stage mycosis fungoides: development and validation in a Danish nationwide study.
    Lindahl LM; Besenbacher S; Rittig AH; Celis P; Willerslev-Olsen A; Gjerdrum LMR; Krejsgaard T; Johansen C; Litman T; Woetmann A; Odum N; Iversen L
    Blood; 2018 Feb; 131(7):759-770. PubMed ID: 29208599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Lymphoma International Consortium Study of Outcome in Advanced Stages of Mycosis Fungoides and Sézary Syndrome: Effect of Specific Prognostic Markers on Survival and Development of a Prognostic Model.
    Scarisbrick JJ; Prince HM; Vermeer MH; Quaglino P; Horwitz S; Porcu P; Stadler R; Wood GS; Beylot-Barry M; Pham-Ledard A; Foss F; Girardi M; Bagot M; Michel L; Battistella M; Guitart J; Kuzel TM; Martinez-Escala ME; Estrach T; Papadavid E; Antoniou C; Rigopoulos D; Nikolaou V; Sugaya M; Miyagaki T; Gniadecki R; Sanches JA; Cury-Martins J; Miyashiro D; Servitje O; Muniesa C; Berti E; Onida F; Corti L; Hodak E; Amitay-Laish I; Ortiz-Romero PL; Rodríguez-Peralto JL; Knobler R; Porkert S; Bauer W; Pimpinelli N; Grandi V; Cowan R; Rook A; Kim E; Pileri A; Patrizi A; Pujol RM; Wong H; Tyler K; Stranzenbach R; Querfeld C; Fava P; Maule M; Willemze R; Evison F; Morris S; Twigger R; Talpur R; Kim J; Ognibene G; Li S; Tavallaee M; Hoppe RT; Duvic M; Whittaker SJ; Kim YH
    J Clin Oncol; 2015 Nov; 33(32):3766-73. PubMed ID: 26438120
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time course, clinical pathways, and long-term hazards risk trends of disease progression in patients with classic mycosis fungoides: a multicenter, retrospective follow-up study from the Italian Group of Cutaneous Lymphomas.
    Quaglino P; Pimpinelli N; Berti E; Calzavara-Pinton P; Alfonso Lombardo G; Rupoli S; Alaibac M; Bottoni U; Carbone A; Fava P; Fimiani M; Mamusa AM; Titli S; Zinzani PL; Bernengo MG;
    Cancer; 2012 Dec; 118(23):5830-9. PubMed ID: 22674564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
    Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
    Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes and prognostic factors in African American and black patients with mycosis fungoides/Sézary syndrome: Retrospective analysis of 157 patients from a referral cancer center.
    Geller S; Lebowitz E; Pulitzer MP; Horwitz SM; Moskowitz AJ; Dusza S; Myskowski PL
    J Am Acad Dermatol; 2020 Aug; 83(2):430-439. PubMed ID: 31499157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The PROCLIPI international registry of early-stage mycosis fungoides identifies substantial diagnostic delay in most patients.
    Scarisbrick JJ; Quaglino P; Prince HM; Papadavid E; Hodak E; Bagot M; Servitje O; Berti E; Ortiz-Romero P; Stadler R; Patsatsi A; Knobler R; Guenova E; Child F; Whittaker S; Nikolaou V; Tomasini C; Amitay I; Prag Naveh H; Ram-Wolff C; Battistella M; Alberti-Violetti S; Stranzenbach R; Gargallo V; Muniesa C; Koletsa T; Jonak C; Porkert S; Mitteldorf C; Estrach T; Combalia A; Marschalko M; Csomor J; Szepesi A; Cozzio A; Dummer R; Pimpinelli N; Grandi V; Beylot-Barry M; Pham-Ledard A; Wobser M; Geissinger E; Wehkamp U; Weichenthal M; Cowan R; Parry E; Harris J; Wachsmuth R; Turner D; Bates A; Healy E; Trautinger F; Latzka J; Yoo J; Vydianath B; Amel-Kashipaz R; Marinos L; Oikonomidi A; Stratigos A; Vignon-Pennamen MD; Battistella M; Climent F; Gonzalez-Barca E; Georgiou E; Senetta R; Zinzani P; Vakeva L; Ranki A; Busschots AM; Hauben E; Bervoets A; Woei-A-Jin FJSH; Matin R; Collins G; Weatherhead S; Frew J; Bayne M; Dunnill G; McKay P; Arumainathan A; Azurdia R; Benstead K; Twigger R; Rieger K; Brown R; Sanches JA; Miyashiro D; Akilov O; McCann S; Sahi H; Damasco FM; Querfeld C; Folkes A; Bur C; Klemke CD; Enz P; Pujol R; Quint K; Geskin L; Hong E; Evison F; Vermeer M; Cerroni L; Kempf W; Kim Y; Willemze R
    Br J Dermatol; 2019 Aug; 181(2):350-357. PubMed ID: 30267549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics, prognostic factors, and survival of 393 patients with mycosis fungoides and Sézary syndrome in the southeastern United States: a single-institution cohort.
    Desai M; Liu S; Parker S
    J Am Acad Dermatol; 2015 Feb; 72(2):276-85. PubMed ID: 25458019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA expression in early mycosis fungoides is distinctly different from atopic dermatitis and advanced cutaneous T-cell lymphoma.
    Ralfkiaer U; Lindahl LM; Litman T; Gjerdrum LM; Ahler CB; Gniadecki R; Marstrand T; Fredholm S; Iversen L; Wasik MA; Bonefeld CM; Geisler C; Krejsgaard T; Glue C; Røpke MA; Woetmann A; Skov L; Grønbæk K; Odum N
    Anticancer Res; 2014 Dec; 34(12):7207-17. PubMed ID: 25503151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic imbalances and microRNA transcriptional profiles in patients with mycosis fungoides.
    Garaicoa FH; Roisman A; Arias M; Trila C; Fridmanis M; Abeldaño A; Vanzulli S; Narbaitz M; Slavutsky I
    Tumour Biol; 2016 Oct; 37(10):13637-13647. PubMed ID: 27473081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Translated article] Survival Analysis and Prognostic Factors in a Case Series of 148 Cutaneous T-Cell Lymphomas.
    Moreno-Vílchez C; Servitje O; Íñiguez-Arroyo Ó; Muniesa C
    Actas Dermosifiliogr; 2024 Sep; 115(8):T766-T772. PubMed ID: 38972577
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides.
    Sufficool KE; Lockwood CM; Abel HJ; Hagemann IS; Schumacher JA; Kelley TW; Duncavage EJ
    J Am Acad Dermatol; 2015 Aug; 73(2):228-36.e2. PubMed ID: 26048061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis.
    Alberti-Violetti S; Sapienza MR; Del Corvo M; Melle F; Motta G; Venegoni L; Cerroni L; Cota C; Pileri A; Berti E; Pileri SA
    Cells; 2023 Jul; 12(15):. PubMed ID: 37566023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of progression of early-stage mycosis fungoides, 10-year experience.
    Ariza Gómez SA; Dubeibe Abril PA; Niebles Sincelejo OE; Reina HSL
    An Bras Dermatol; 2024; 99(3):407-413. PubMed ID: 38395632
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptomic changes during stage progression of mycosis fungoides.
    Xiao MZX; Hennessey D; Iyer A; O'Keefe S; Zhang F; Sivanand A; Gniadecki R
    Br J Dermatol; 2022 Mar; 186(3):520-531. PubMed ID: 34528236
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Survival outcomes and prognostic factors in mycosis fungoides/Sézary syndrome: validation of the revised International Society for Cutaneous Lymphomas/European Organisation for Research and Treatment of Cancer staging proposal.
    Agar NS; Wedgeworth E; Crichton S; Mitchell TJ; Cox M; Ferreira S; Robson A; Calonje E; Stefanato CM; Wain EM; Wilkins B; Fields PA; Dean A; Webb K; Scarisbrick J; Morris S; Whittaker SJ
    J Clin Oncol; 2010 Nov; 28(31):4730-9. PubMed ID: 20855822
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Neoantigen Landscape of Mycosis Fungoides.
    Sivanand A; Hennessey D; Iyer A; O'Keefe S; Surmanowicz P; Vaid G; Xiao Z; Gniadecki R
    Front Immunol; 2020; 11():561234. PubMed ID: 33329522
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.